Welcome to our dedicated page for TERADYNE SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TERADYNE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TERADYNE's regulatory disclosures and financial reporting.
Teradyne, Inc. President and CEO Gregory Stephen Smith reported an open-market sale of 4,000 shares of common stock on July 15, 2026 at $356.31 per share. The transaction was effected under a sales plan adopted on February 12, 2026 intended to comply with Rule 10b5-1. After the sale, he holds 116,495.4075 shares directly, including 25.8346 shares acquired through the Employee Stock Purchase Plan on June 30, 2026.
Teradyne director Marilyn Matz executed an open-market sale of 1,200 shares of common stock at $356.31 per share on July 15, 2026. Following the sale, she holds 16,240.675 shares directly. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 13, 2026.
Security holder Marilyn Matz filed a notice related to issuer TER to sell 1200 shares of common stock through Fidelity Brokerage on NASDAQ, with an aggregate market value of 427572.00 as of 07/15/2026. Disclosed recent sales include 800, 400 and 1200 shares in May and June 2026.
Gregory S. Smith filed a Form 144 relating to Teradyne common stock, indicating a proposed sale of 4,000 shares through Fidelity Brokerage Services LLC, with an aggregate market value of $1,425,240.00 and an approximate sale date of July 15, 2026. These shares were acquired from the issuer on January 27, 2026 via Restricted Stock Vesting as compensation. The notice also lists prior sales in the past three months of 8,597 and 4,000 shares on May 15 and June 15, 2026, for gross proceeds of $2,914,211.06 and $1,692,120.00, respectively.
Teradyne director Mercedes Johnson reported a small open-market sale of company stock. She sold 167 shares of Common Stock at a price of $460.00 per share in a transaction classified as an open-market sale. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2026, indicating it was scheduled in advance. After the sale, she directly holds 6,697 shares and indirectly holds 1,876 shares through The Mercedes Johnson Trust, where she is trustee and sole beneficiary.
Mercedes Johnson submitted a Form 144 notice related to Common Stock tied to a prior restricted stock vesting event. The filing lists recent dispositions of 625 shares on 04/06/2026 for $195,125.00 and 167 shares on 06/02/2026 for $61,746.58.
TERADYNE, INC director Paul J. Tufano increased his equity-based holdings through a compensation deferral. On this Form 4, he acquired 116 shares of Common Stock-equivalent deferred stock units at no cash cost, bringing his directly held total to 65,848 shares. The units represent quarterly cash fees deferred into stock-based compensation.
Teradyne, Inc. director Henry Andrew Chisholm reported a routine compensation-related transaction in the form of deferred stock units. On the reported date, he acquired 52 units of Common Stock at no cash cost as a grant or award, reflecting his deferral of quarterly cash compensation into deferred stock units. Following this transaction, he directly holds 2,927 shares or units tied to Common Stock. The deferred stock units are calculated based on the closing price on their issuance date and are generally settled one-for-one in Common Stock within ninety days after he stops serving as a non-employee director.
TERADYNE, INC director Peter Herweck increased his equity stake through deferred stock compensation. He acquired 63 shares of Common Stock at a stated price of $0.00 per share as a grant/award tied to his quarterly cash compensation.
Following this award, Herweck directly holds 16,201 shares of Common Stock. According to the disclosure, this represents a deferral of his quarterly cash compensation into deferred stock units, which are calculated using the closing price of the stock on the issuance date and are settled one-for-one in Common Stock after he no longer serves as a non-employee director.
Teradyne, Inc. director Marilyn Matz sold 1,200 shares of Common Stock at $423.03 per share in an open-market transaction. After the sale, she directly holds 17,440.675 shares. The trade was carried out under a pre-arranged Rule 10b5-1 sales plan adopted on February 13, 2026.